3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
23
Terminated
7
Recruiting
3
Unknown
2
Active not recruiting
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
6
Myelodysplastic Syndromes
4
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Melanoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia
1
Carcinoma, Squamous Cell
1
Interventions
Cyclophosphamide
10
fludarabine phosphate
9
Rituximab
9
Cytarabine
9
Peripheral Blood Stem Cell Transplantation
8
Methotrexate
8
Filgrastim
6
Cyclosporine
6
fludarabine
5
Radiotherapy
5
Busulfan
5
Tacrolimus
4
Mycophenolic Acid
4
Idarubicin
4
Granulocyte Colony-Stimulating Factor
4
Bendamustine Hydrochloride
4
venetoclax
3
duvelisib
3
Whole-Body Irradiation
3
Sirolimus
3
Melphalan
3
Antilymphocyte Serum
3
Prednisone
2
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
2
Mitoxantrone
2
Lenalidomide
2
Interferon-alpha
2
Drug Therapy
2
Clofarabine
2
Arsenic Trioxide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Leukemia
×
Decitabine
×
Clear all
NCT05740449
2024-06-21
HEM-iSMART A
Princess Maxima Center for Pediatric Oncology
Phase 1/2
Withdrawn